Genomics in action

Our response to AHA statement on polygenic risk scores

New and improved polygenic risk scores for 28 common diseases

Enrolment has closed in our NHS HEART study

NHS pilots genetic testing to predict risk of heart disease

Genomics plc’s approach to safety regulations, standards and requirements

Genomics plc announces extension of drug discovery collaboration with Vertex

Genomics plc featured as one of the U.K. Genomics Startups Changing The Future Of Healthcare Forever in Forbes

Genomics plc founder and CEO, Sir Peter Donnelly, awarded Royal Society Gabor medal

NHS launches new polygenic scores trial for heart disease

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities

Genomics plc founder Sir Peter Donnelly discusses DNA trials in The Evening Standard

Sir Peter Donnelly gives Plenary Keynote at ELRIG Research & Innovation 2021

Our CEO Peter Donnelly speaks with John Pienaar at The Times Radio

Genomics plc discusses genomic prevention in The Times

Genomics plc’s integrated risk tool substantially improves coronary artery disease prediction